(Total Views: 527)
Posted On: 06/22/2020 10:47:11 PM
Post# of 72440
The numbers they are talking must be only for Kevetrin as a stand alone product.
It's truly hidden value could lay in the fact that it should be able to complement just about every current cancer drug treatment available today by desensitizing the cells and making them more acceptable by the body. Many of these drugs are getting near their end of patent protected period and adding K would allow BPs to extend their patents for another full term.
I have always heard the market for cancer drugs is $100B+/yr
Just like B, K has layers of very positive features.
It's truly hidden value could lay in the fact that it should be able to complement just about every current cancer drug treatment available today by desensitizing the cells and making them more acceptable by the body. Many of these drugs are getting near their end of patent protected period and adding K would allow BPs to extend their patents for another full term.
I have always heard the market for cancer drugs is $100B+/yr
Just like B, K has layers of very positive features.
(4)
(0)Scroll down for more posts ▼
